OncoVista Innovative Therapies, Inc.
OVIT
$0.0001
-$0.0001-50.00%
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -3.27M | -2.72M | -2.51M | -2.54M | -1.35M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 500.00 | 500.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 613.70K | -677.00K | -71.80K | -8.80K | 90.40K |
| Change in Net Operating Assets | 2.39M | 3.08M | 2.30M | 2.32M | 1.06M |
| Cash from Operations | -264.40K | -317.90K | -283.80K | -232.30K | -199.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 250.00K | 290.00K | 310.00K | 200.00K | 200.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 250.00K | 290.00K | 310.00K | 200.00K | 200.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.40K | -27.90K | 26.20K | -32.30K | 500.00 |